You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
|
|---|---|
| Published in |
The Lancet Diabetes & Endocrinology, February 2014
|
| DOI | 10.1016/s2213-8587(13)70170-0 |
| Pubmed ID | |
| Authors |
Norbert Stefan, Markus Ramsauer, Paul Jordan, Bettina Nowotny, Konstantinos Kantartzis, Jürgen Machann, Jong-Hee Hwang, Peter Nowotny, Sabine Kahl, Jürgen Harreiter, Silke Hornemann, Arun J Sanyal, Paul M Stewart, Andreas F Pfeiffer, Alexandra Kautzky-Willer, Michael Roden, Hans-Ulrich Häring, Sabine Fürst-Recktenwald |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 33% |
| United States | 2 | 33% |
| Canada | 1 | 17% |
| Unknown | 1 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 33% |
| Scientists | 2 | 33% |
| Members of the public | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Hungary | 1 | <1% |
| Netherlands | 1 | <1% |
| Ireland | 1 | <1% |
| Unknown | 130 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 17% |
| Student > Master | 18 | 14% |
| Student > Bachelor | 14 | 11% |
| Student > Ph. D. Student | 12 | 9% |
| Other | 9 | 7% |
| Other | 21 | 16% |
| Unknown | 36 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 30% |
| Biochemistry, Genetics and Molecular Biology | 9 | 7% |
| Agricultural and Biological Sciences | 8 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
| Nursing and Health Professions | 5 | 4% |
| Other | 20 | 15% |
| Unknown | 45 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 41. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2022.
All research outputs
#1,000,580
of 25,374,917 outputs
Outputs from The Lancet Diabetes & Endocrinology
#661
of 2,140 outputs
Outputs of similar age
#9,753
of 238,196 outputs
Outputs of similar age from The Lancet Diabetes & Endocrinology
#11
of 66 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 76.3. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,196 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.